Tesla Earnings Beat Expectations as EV Growth Holds Amid Robotics and AI Shift 
DeepSeek Launches V4 AI Models with Enhanced Reasoning and 1M Token Context Window 
U.S. Sanctions Target Chinese Refinery Over Iranian Oil Purchases 
$16B Michigan Data Center Project Boosts U.S. AI Infrastructure Expansion 
SpaceX President Gwynne Shotwell Earns $85.8M as IPO Buzz Grows 
Intel Stock Surges as AI Chip Demand Drives Strong Q2 Forecast 
Rising Jet Fuel Costs from Iran Conflict Push Airfare Higher Across Europe 
Judge Dismisses Elon Musk’s Fraud Claims Against OpenAI, Trial to Proceed on Remaining Allegations 
PLS Reports Record Lithium Output as EV Demand Fuels Market Growth 
Meta Expands AI Training With Employee Activity Tracking Tools 
Mercedes-Benz Faces Rising Competition in China but Rejects Price War Strategy 
Florida Launches Criminal Probe Into OpenAI Over FSU Shooting Incident 
Why Global Web3 Projects Can't Afford to Skip South Korea: TokenPost Unveils Data-Driven Entry Solutions 
European Car Sales Surge in March as EV and Hybrid Demand Accelerates 
Amazon Stock Rises as Meta Expands AWS Partnership for AI Infrastructure 
Nvidia Pushes 800V Data Center Power Systems to Boost Efficiency and Cut Costs 
Elon Musk Signals Intel 14A Chips for Tesla’s Terafab AI Semiconductor Venture 
- The ROTH conference brings together several thousand U.S. investors focused on small and mid-cap growth companies.
- Emmanuel PETIOT will present the Company on Tuesday, March 15th, 2016.
MONTPELLIER, France, March 1, 2016 -- DEINOVE (Alternext Paris: ALDEI), a biotech company developing innovative processes for producing biofuels and bio-based chemicals by using Deinococcus bacteria as host strains, announces that Emmanuel PETIOT, Chief Executive Officer, will present at the 28th annual ROTH conference within the "Cleantech and Industrial growth" track, in Dana Point, CA, United States.
He will speak on Tuesday, March 15th, at 5:30 p.m. local time and will also meet one-on-one with investors.
A live webcast of the conference presentation will be available on the Investor Relations section of DEINOVE's website:
http://www.deinove.com/en/investor-room/documentation-center/presentations-shareholders
A replay of the webcast will also be available on this site for 90 days following the live event.
About the ROTH Conference
The 28th annual ROTH Conference, hosted by Roth Capital Partners, is one of the largest of its kind in the U.S. with over 3,000 attendees each year. It will be held on March 13-16, 2016 at The Ritz Carlton in Dana Point, California. The conference will feature company presentations, expert panels and one-on-one meetings.
About DEINOVE
DEINOVE (Alternext Paris: ALDEI) is ushering in a new era of green chemistry by designing and developing new standards of production based on bacteria of untapped potential: the Deinococci. Taking advantage of the bacteria's unique genetic properties and unusual robustness, DEINOVE optimizes natural fermentation and metabolic capabilities of these bacterial "micro-factories" to produce high value-added products from non-food biomass. The Company's primary markets are 2nd-generation biofuels (DEINOL) and bio-based chemicals (DEINOCHEM). On these markets, the Company offers its technology to industrial partners globally. Listed on NYSE Alternext since April 2010, DEINOVE was founded by Dr. Philippe Pouletty, General Partner of TRUFFLE CAPITAL, and Pr. Miroslav Radman, of the Faculty of Medicine of Paris Descartes University. The company employs almost 50 people in its offices and laboratories located in Montpellier, France.
More information at www.deinove.com
Contacts
|
DEINOVE Emmanuel Petiot CEO Tel.: +33 (0)4 48 19 01 28 [email protected] |
Coralie Martin Communication, Marketing and IR Manager Tel.: +33 (0)4 48 19 01 60 [email protected] |
|
ALIZE RP, Press Relations Caroline Carmagnol / Wendy Rigal Tel.: +33 (0)1 44 54 36 66 [email protected] |
PR DEINOVE ROTH conference http://hugin.info/142979/R/1990663/731435.pdf
HUG#1990663
